Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRIME: Aprovel in Chinese Hypertensive Type 2 Diabetic Patients with Microalbuminuria
NCT00561964Phase 3Completed
- Sponsor
- Sanofi
- Start
- Jan 2004
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of irbesartan in diabetic nephropathy (DN), hypertension (HTN), sponsored by Sanofi. Started Jan 2004; status: completed.
02
Drugs
irbesartan
03
Conditions
diabetic nephropathy (DN)hypertension (HTN)
Beyond the preview
Go deeper on NCT00561964.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00561964.